Trading Summary - August 8. Another satisfactory status

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
231
Trading Summary - August 8.

Another satisfactory status quo day for $EVSV whilst most top traders were busy elsewhere on $VYST (Watch list #1 Pick of 2019 - $EVSV remains #3) which was the major runner today - with reload opportunities - on great unexpected news.

The usual cat and mouse game between multiple bidders and manipulators continued today - with one paint down bought by a bidder and 2 x ask buys.

Overall, another 1,009 shares were bought today at the same price point as yesterday.

The 2019 Q2 was filed yesterday in a timely manner (see separate post) and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

The following items below the line unchanged since the last Trading Summary:

We now have a confirmed target date of mid-September for the harvest of the first hemp crop at the first of several planned production sites.

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

Don't expect much to be made available under 1.000.

For those who have been following the "trading successfully through a r/s strategy" since the warning day on January 24, even those who failed to buy in the .4000 > .7150 range over the past 6+ months still have a chance to buy more shares in the .7700 > 1.600 range before the pre-r/s shares come in to play.

The pre-r/s shares from legacy holders aren't going to be significant in number under 2.000 - as is well known to those who were trading in the .0007 > .0011 range pre-r/s for 2 reasons:

- Many amateur iHub mentality traders needlessly sell for a loss as a matter of course as soon as warning is given of a r/s - reducing drastically the number of shares at the former flipper log jam price (which was 1.4000 > 2.000 in "new money".

- Those that kept their shares have had them divided by 2000 - so insignificant in the grand scheme of things bearing in mind we are looking at NASDAQ price levels for $EVSV now.

On July 29, 2019 the Transfer Agent updated the Verified Company Profile early to confirm both no dilution of the Common Unrestricted shares and the previously announced 50,000 share reduction - with more known to be coming and a possible share buyback by the company as well.

Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dermatology Access Expands in Kansas With Expert Return

Updated Category News Views 23

Jenna King's Return Elevates Local Care Who says you can't go home again? Jenna King, a familiar face in Southeast Kansas, is back to serve her community by upping the ante in dermatology care at U.S. Dermatology Partners in Pittsburg. After gaining experience in Oklahoma, she's here to extend both medical and cosmetic treatments to her neighbors. Why Her Return Is a Game...

Continue Reading
Direxion Targets Anthropic's IPO with Bold New ETFs

Updated Category News Views 40

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Continue Reading
Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Updated Category News Views 126

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Continue Reading
Entangled 2026 Summit: Driving Quantum, AI, & Biotech Synergy

Updated Category News Views 36

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Continue Reading
Pozdeutinurad Phase 3 Success Impact on Sobi and Market

Updated Category News Views 70

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Continue Reading
P.S. Active Teams with Barrett for Logistics Boost

Updated Category News Views 9

Barrett Gets in the Game with P.S. Active Alright, picture this: an activewear brand hooked up with a logistics heavyweight. No, it's not just another round of corporate muscle-flexing—it's P.S. Active, spearheaded by Erika Hammond, partnering with Barrett Distribution Centers to elevate their fulfillment game from New Jersey's Somerset hub. The Stakes: More Than Just...

Continue Reading
Fan Creations Shine: McLaren's Unique Livery Unveiled

Updated Category News Views 98

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

Continue Reading
ServiceNow Faces Legal Probe Amid Stock Slide

Updated Category News Views 52

Stock Turbulence Hits ServiceNow Investors Wake up and smell the market correction! ServiceNow's done slapped its shareholders with a situation no one saw coming—or maybe not. When the market opened on October 29, NYSE:NOW shares weren't just dipping; they were diving off a $29 cliff, all thanks to some sour guidance for fourth-quarter growth. Talk about financial...

Continue Reading
Cat Financial Shows Solid Q3 Growth Amid Challenges

Updated Category News Views 82

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

Continue Reading
Busch Gardens' Holiday Extravaganza Lights Up 2026

Updated Category News Views 30

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

Continue Reading

Top 5 Most Recently Viewed Articles

PharmaTher's Bold Plans for Ketamine Market Domination

Updated Category News Views 127

PharmaTher's Roadmap to Ketamine Commercialization PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a pioneering specialty pharmaceutical firm, is steering its focus towards the development and commercialization of ketamine-based therapies. The Company has carved out an impressive path for itself as it aspires to lead in unlocking the...

Continue Reading
Causum's Mars® Emerges as Key AI Governance Tool for Firms

Updated Category News Views 175

The Rise of AI Governance in a Chaotic Landscape Here we are, on the cusp of a tech revolution where regulations are starting to tighten around AI like a vise. You remember those wild days back during the dot-com boom, right? Everyone was scrambling to cash in on tech, while the ground rules were still being drawn up. Well, history's repeating itself—only this time,...

Continue Reading
Parsons Corporation to Share Insights at Key Financial Conference

Updated Category News Views 309

Parsons Corporation's Upcoming Conference Presentation Parsons Corporation will soon take the stage at a significant financial event known as the Raymond James 46th Annual Institutional Investors Conference. This prestigious conference is an excellent opportunity for the company to engage with investors and provide insights into its strategic direction. Featured Speakers...

Continue Reading
Innovative Mud Cleaning Tool Revolutionizes Home Renovations

Updated Category News Views 213

Revolutionizing Mud Pan Cleaning with Innovative Design Meet a groundbreaking solution for home renovation enthusiasts and professionals alike—an inventive tool designed specifically for cleaning mud pans efficiently and effectively. This innovative product stems from the extensive experience of a skilled drywall finisher who spent 40 years in the industry, identifying...

Continue Reading
Brookfield Asset Management Achieves New Heights with BAM Stock

Updated Category News Views 108

Brookfield Asset Management Achieves New Heights with BAM Stock Brookfield Asset Management Inc (TSX: BAM) recently celebrated a major milestone as its stock reached an impressive 52-week high of $47.45. This achievement demonstrates the company’s strong growth trajectory and effective strategies in place. Investors are showing increased confidence in BAM’s unique...

Continue Reading